CFG
BSX icon

Clayton Financial Group’s Boston Scientific BSX Stock Holding History

Clayton Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,448
Closed -$90.9K – 134
2026
Q1 		$90.9K Hold
1,448
– – 0.05% 106
2025
Q4 		$138K Buy
+1,448
New +$142K 0.07% 93

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
MF
Milford Funds Auckland $6.14B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Clayton Financial Group's BSX Position: Q2 2026 in Review

Clayton Financial Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 1,448 shares — an estimated $90.9K sold.

Clayton Financial Group first reported a position in BSX in Q4 2025 and held it in 2 quarters. The position peaked at $138K in Q4 2025. 495 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Clayton Financial Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Clayton Financial Group sold 1,448 Boston Scientific shares in Q2 2026, an estimated $90.9K.
  • Clayton Financial Group first reported a position in Boston Scientific in Q4 2025 and held it in 2 quarters.
  • Clayton Financial Group's Boston Scientific position peaked at $138K in Q4 2025.
  • 495 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.